Skip to main content
Erschienen in: Journal of Neuroinflammation 1/2010

Open Access 01.12.2010 | Research

Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades

verfasst von: Mei-Jen Wang, Hsin-Yi Huang, Wu-Fu Chen, Hui-Fen Chang, Jon-Son Kuo

Erschienen in: Journal of Neuroinflammation | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Deciphering the mechanisms that modulate the inflammatory response induced by microglial activation not only improves our insight into neuroinflammation but also provides avenues for designing novel therapies that could halt inflammation-induced neuronal degeneration. Decreasing glycogen synthase kinase-3β (GSK-3β) activity has therapeutic benefits in inflammatory diseases. However, the exact molecular mechanisms underlying GSK-3β inactivation-mediated suppression of the inflammatory response induced by microglial activation have not been completely clarified. Tumor necrosis factor-α (TNF-α) plays a central role in injury caused by neuroinflammation. We investigated the regulatory effect of GSK-3β on TNF-α production by microglia to discern the molecular mechanisms of this modulation.

Methods

Lipopolysaccharide (LPS) was used to induce an inflammatory response in cultured primary microglia or murine BV-2 microglial cells. Release of TNF-α was measured by ELISA. Signaling molecules were analyzed by western blotting, and activation of NF-κB and AP-1 was measured by ELISA-based DNA binding analysis and luciferase reporter assay. Protein interaction was examined by coimmunoprecipitation.

Results

Inhibition of GSK-3β by selective GSK-3β inhibitors or by RNA interference attenuated LPS-induced TNF-α production in cultured microglia. Exploration of the mechanisms by which GSK-3β positively regulates inflammatory response showed that LPS-induced IκB-α degradation, NF-κBp65 nuclear translocation, and p65 DNA binding activity were not affected by inhibition of GSK-3β activity. However, GSK-3β inactivation inhibited transactivation activity of p65 by deacetylating p65 at lysine 310. Furthermore, we also demonstrated a functional interaction between mixed lineage kinase 3 (MLK3) and GSK-3β during LPS-induced TNF-α production in microglia. The phosphorylated levels of MLK3, MKK4, and JNK were increased upon LPS treatment. Decreasing GSK-3β activity blocked MLK3 signaling cascades through disruption of MLK3 dimerization-induced autophosphorylation, ultimately leading to a decrease in TNF-α secretion.

Conclusion

These results suggest that inactivation of GSK-3β might represent a potential strategy to downregulate microglia-mediated inflammatory processes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mrak RE, Griffin WS: Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging. 2005, 26: 349-354. 10.1016/j.neurobiolaging.2004.05.010.CrossRefPubMed Mrak RE, Griffin WS: Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging. 2005, 26: 349-354. 10.1016/j.neurobiolaging.2004.05.010.CrossRefPubMed
2.
Zurück zum Zitat Wyss-Coray T: Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med. 2006, 12: 1005-1015.PubMed Wyss-Coray T: Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med. 2006, 12: 1005-1015.PubMed
3.
Zurück zum Zitat McGeer PL, McGeer EG: Glial reactions in Parkinson's disease. Mov Disord. 2008, 23: 474-483. 10.1002/mds.21751.CrossRefPubMed McGeer PL, McGeer EG: Glial reactions in Parkinson's disease. Mov Disord. 2008, 23: 474-483. 10.1002/mds.21751.CrossRefPubMed
4.
Zurück zum Zitat Grimes CA, Jope RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001, 65: 391-426. 10.1016/S0301-0082(01)00011-9.CrossRefPubMed Grimes CA, Jope RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001, 65: 391-426. 10.1016/S0301-0082(01)00011-9.CrossRefPubMed
5.
Zurück zum Zitat Jiang H, Guo W, Liang X, Rao Y: Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators. Cell. 2005, 120: 123-135.PubMed Jiang H, Guo W, Liang X, Rao Y: Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators. Cell. 2005, 120: 123-135.PubMed
6.
Zurück zum Zitat Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB: Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling. Mol Cell Biol. 2003, 23: 4649-4662. 10.1128/MCB.23.13.4649-4662.2003.PubMedCentralCrossRefPubMed Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB: Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling. Mol Cell Biol. 2003, 23: 4649-4662. 10.1128/MCB.23.13.4649-4662.2003.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K, Kracht M: Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity. J Biol Chem. 2004, 279: 49571-49574. 10.1074/jbc.C400442200.CrossRefPubMed Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K, Kracht M: Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity. J Biol Chem. 2004, 279: 49571-49574. 10.1074/jbc.C400442200.CrossRefPubMed
8.
Zurück zum Zitat Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB: Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Biol Chem. 2004, 279: 39541-39554. 10.1074/jbc.M403449200.CrossRefPubMed Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB: Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Biol Chem. 2004, 279: 39541-39554. 10.1074/jbc.M403449200.CrossRefPubMed
9.
Zurück zum Zitat Shen E, Fan J, Peng T: Glycogen synthase kinase-3beta suppresses tumor necrosis factor-alpha expression in cardiomyocytes during lipopolysaccharide stimulation. J Cell Biochem. 2008, 104: 329-338. 10.1002/jcb.21629.CrossRefPubMed Shen E, Fan J, Peng T: Glycogen synthase kinase-3beta suppresses tumor necrosis factor-alpha expression in cardiomyocytes during lipopolysaccharide stimulation. J Cell Biochem. 2008, 104: 329-338. 10.1002/jcb.21629.CrossRefPubMed
10.
Zurück zum Zitat Vines A, Cahoon S, Goldberg I, Saxena U, Pillarisetti S: Novel inflammatory role for glycogen synthase-3β in the inhibition of TNF-α and IL-1β induced inflammatory gene expression. J Biol Chem. 2006, 281: 16985-16990. 10.1074/jbc.M602446200.CrossRefPubMed Vines A, Cahoon S, Goldberg I, Saxena U, Pillarisetti S: Novel inflammatory role for glycogen synthase-3β in the inhibition of TNF-α and IL-1β induced inflammatory gene expression. J Biol Chem. 2006, 281: 16985-16990. 10.1074/jbc.M602446200.CrossRefPubMed
11.
Zurück zum Zitat Martin M, Rehani K, Jope RS, Michalek SM: Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005, 6: 777-784. 10.1038/ni1221.PubMedCentralCrossRefPubMed Martin M, Rehani K, Jope RS, Michalek SM: Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005, 6: 777-784. 10.1038/ni1221.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Huang WC, Lin YS, Wang CY, Tsai CC, Tseng HC, Chen CL, Lu PJ, Chen PS, Qian L, Hong JS, Lin CF: Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology. 2009, 128: e275-286. 10.1111/j.1365-2567.2008.02959.x.PubMedCentralCrossRefPubMed Huang WC, Lin YS, Wang CY, Tsai CC, Tseng HC, Chen CL, Lu PJ, Chen PS, Qian L, Hong JS, Lin CF: Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology. 2009, 128: e275-286. 10.1111/j.1365-2567.2008.02959.x.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Yuskaitis CJ, Jope RS: Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal. 2009, 21: 264-273. 10.1016/j.cellsig.2008.10.014.PubMedCentralCrossRefPubMed Yuskaitis CJ, Jope RS: Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal. 2009, 21: 264-273. 10.1016/j.cellsig.2008.10.014.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Colasanti M, Persichini T, Pucchio TDi, Gremo F, Lauro GM: Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor alpha stimulation. Neurosci Lett. 1995, 200: 144-146. 10.1016/0304-3940(95)12101-9.CrossRefPubMed Colasanti M, Persichini T, Pucchio TDi, Gremo F, Lauro GM: Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor alpha stimulation. Neurosci Lett. 1995, 200: 144-146. 10.1016/0304-3940(95)12101-9.CrossRefPubMed
15.
Zurück zum Zitat Marcus JS, Karackattu SL, Fleegal MA, Sumners C: Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia. 2003, 41: 152-160. 10.1002/glia.10168.CrossRefPubMed Marcus JS, Karackattu SL, Fleegal MA, Sumners C: Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia. 2003, 41: 152-160. 10.1002/glia.10168.CrossRefPubMed
16.
Zurück zum Zitat Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W: Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J Biol Chem. 1992, 267: 5317-5323.PubMed Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W: Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J Biol Chem. 1992, 267: 5317-5323.PubMed
17.
Zurück zum Zitat Goossens V, Grooten J, De Vos K, Fiers W: Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA. 1995, 92: 8115-8119. 10.1073/pnas.92.18.8115.PubMedCentralCrossRefPubMed Goossens V, Grooten J, De Vos K, Fiers W: Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA. 1995, 92: 8115-8119. 10.1073/pnas.92.18.8115.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995, 81: 495-504. 10.1016/0092-8674(95)90070-5.CrossRefPubMed Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995, 81: 495-504. 10.1016/0092-8674(95)90070-5.CrossRefPubMed
19.
Zurück zum Zitat Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, Wolf-Klein G: Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett. 1991, 129: 318-320. 10.1016/0304-3940(91)90490-K.CrossRefPubMed Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, Wolf-Klein G: Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett. 1991, 129: 318-320. 10.1016/0304-3940(91)90490-K.CrossRefPubMed
20.
Zurück zum Zitat Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T: Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994, 165: 208-210. 10.1016/0304-3940(94)90746-3.CrossRefPubMed Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T: Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994, 165: 208-210. 10.1016/0304-3940(94)90746-3.CrossRefPubMed
21.
Zurück zum Zitat Raine CS: Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol. 1994, 53: 328-337. 10.1097/00005072-199407000-00002.CrossRefPubMed Raine CS: Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol. 1994, 53: 328-337. 10.1097/00005072-199407000-00002.CrossRefPubMed
22.
Zurück zum Zitat Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, Mora G, Camana C, Mazzini L, Bachetti T: Circulating levels of tumor necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett. 2000, 287: 211-214. 10.1016/S0304-3940(00)01177-0.CrossRefPubMed Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, Mora G, Camana C, Mazzini L, Bachetti T: Circulating levels of tumor necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett. 2000, 287: 211-214. 10.1016/S0304-3940(00)01177-0.CrossRefPubMed
23.
Zurück zum Zitat Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP: Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implication for Parkinson's disease. FASEB J. 2002, 16: 1474-1476.PubMed Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP: Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implication for Parkinson's disease. FASEB J. 2002, 16: 1474-1476.PubMed
24.
Zurück zum Zitat McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG: Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci. 2006, 26: 9365-9375. 10.1523/JNEUROSCI.1504-06.2006.PubMedCentralCrossRefPubMed McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG: Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci. 2006, 26: 9365-9375. 10.1523/JNEUROSCI.1504-06.2006.PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 1995, 374: 647-650. 10.1038/374647a0.CrossRefPubMed Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 1995, 374: 647-650. 10.1038/374647a0.CrossRefPubMed
26.
Zurück zum Zitat Lio D, Annoni G, Licastro F, Crivello A, Forte GI, Scola L, Colonna-Romano G, Arosio B, Galimberti L, Vergani C, Caruso C: Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev. 2006, 127: 567-571. 10.1016/j.mad.2006.01.015.CrossRefPubMed Lio D, Annoni G, Licastro F, Crivello A, Forte GI, Scola L, Colonna-Romano G, Arosio B, Galimberti L, Vergani C, Caruso C: Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev. 2006, 127: 567-571. 10.1016/j.mad.2006.01.015.CrossRefPubMed
27.
Zurück zum Zitat McAlpine FE, Lee JK, Harms AS, Ruhn KA, Blurton-Jones M, Hong J, Das P, Golde TE, LaFerla FM, Oddo S, Blesch A, Tansey MG: Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis. 2009, 34: 163-177. 10.1016/j.nbd.2009.01.006.PubMedCentralCrossRefPubMed McAlpine FE, Lee JK, Harms AS, Ruhn KA, Blurton-Jones M, Hong J, Das P, Golde TE, LaFerla FM, Oddo S, Blesch A, Tansey MG: Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis. 2009, 34: 163-177. 10.1016/j.nbd.2009.01.006.PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Tobinick EL, Gross H: Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation. 2008, 5: 2-11. 10.1186/1742-2094-5-2.PubMedCentralCrossRefPubMed Tobinick EL, Gross H: Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation. 2008, 5: 2-11. 10.1186/1742-2094-5-2.PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita PS, Hamdheydari L, Mai T, Mou S, Pye QN, Stewart C, west S, Williamson KS, Zemlan F, Hensley K: The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J Neurochem. 2004, 91: 133-143. 10.1111/j.1471-4159.2004.02700.x.CrossRefPubMed West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita PS, Hamdheydari L, Mai T, Mou S, Pye QN, Stewart C, west S, Williamson KS, Zemlan F, Hensley K: The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J Neurochem. 2004, 91: 133-143. 10.1111/j.1471-4159.2004.02700.x.CrossRefPubMed
30.
Zurück zum Zitat Wang M-J, Lin S-Z, Kuo J-S, Huang H-Y, Tzeng S-F, Liao C-H, Chen D-C, Chen W-F: Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol. 2007, 179: 6204-6214.CrossRefPubMed Wang M-J, Lin S-Z, Kuo J-S, Huang H-Y, Tzeng S-F, Liao C-H, Chen D-C, Chen W-F: Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol. 2007, 179: 6204-6214.CrossRefPubMed
31.
Zurück zum Zitat Ding S, Wu TYH, Brinker A, Peters EC, Hur W, Gray NS, Schultz PG: Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci USA. 2003, 100: 7632-7637. 10.1073/pnas.0732087100.PubMedCentralCrossRefPubMed Ding S, Wu TYH, Brinker A, Peters EC, Hur W, Gray NS, Schultz PG: Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci USA. 2003, 100: 7632-7637. 10.1073/pnas.0732087100.PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Covert MW, Leung TH, Gaston JE, Baltimore D: Achieving stability of lipopolysaccharide-induced NF-κB activation. Science. 2005, 309: 1854-1857. 10.1126/science.1112304.CrossRefPubMed Covert MW, Leung TH, Gaston JE, Baltimore D: Achieving stability of lipopolysaccharide-induced NF-κB activation. Science. 2005, 309: 1854-1857. 10.1126/science.1112304.CrossRefPubMed
33.
Zurück zum Zitat Werner SL, Barken D, Hoffmann A: Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science. 2005, 309: 1857-1861. 10.1126/science.1113319.CrossRefPubMed Werner SL, Barken D, Hoffmann A: Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science. 2005, 309: 1857-1861. 10.1126/science.1113319.CrossRefPubMed
34.
Zurück zum Zitat Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G: Transcriptional activation of the NF-kB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 2003, 22: 1313-1324. 10.1093/emboj/cdg139.PubMedCentralCrossRefPubMed Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G: Transcriptional activation of the NF-kB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 2003, 22: 1313-1324. 10.1093/emboj/cdg139.PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Yang F, Tang E, Guan K, Wang C-Y: IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol. 2003, 170: 5630-5635.CrossRefPubMed Yang F, Tang E, Guan K, Wang C-Y: IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol. 2003, 170: 5630-5635.CrossRefPubMed
36.
Zurück zum Zitat Chen L-F, Fischle W, Verdin E, Greene WC: Duration of nuclear NF-κB action regulated by reversible acetylation. Science. 2001, 293: 1653-1657. 10.1126/science.1062374.CrossRef Chen L-F, Fischle W, Verdin E, Greene WC: Duration of nuclear NF-κB action regulated by reversible acetylation. Science. 2001, 293: 1653-1657. 10.1126/science.1062374.CrossRef
37.
Zurück zum Zitat Chen L-F, Mu Y, Greene WC: Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 2002, 21: 6539-6548. 10.1093/emboj/cdf660.PubMedCentralCrossRefPubMed Chen L-F, Mu Y, Greene WC: Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 2002, 21: 6539-6548. 10.1093/emboj/cdf660.PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Bhat NR, Zhang P, Lee JC, Hogan EL: Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinase regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J Neurosci. 1998, 18: 1633-1641.PubMed Bhat NR, Zhang P, Lee JC, Hogan EL: Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinase regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J Neurosci. 1998, 18: 1633-1641.PubMed
39.
Zurück zum Zitat Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature. 1991, 354: 494-496. 10.1038/354494a0.CrossRefPubMed Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature. 1991, 354: 494-496. 10.1038/354494a0.CrossRefPubMed
40.
Zurück zum Zitat Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell. 2000, 103: 239-252. 10.1016/S0092-8674(00)00116-1.CrossRefPubMed Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell. 2000, 103: 239-252. 10.1016/S0092-8674(00)00116-1.CrossRefPubMed
41.
Zurück zum Zitat Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ: MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 2001, 15: 1419-1426. 10.1101/gad.888501.PubMedCentralCrossRefPubMed Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ: MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 2001, 15: 1419-1426. 10.1101/gad.888501.PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Wang X, Destrument A, Tournier C: Physiological roles of MKK4 and MKK7: insights from animal models. Biochim Biophys acta. 2007, 1773: 1349-1357. 10.1016/j.bbamcr.2006.10.016.CrossRefPubMed Wang X, Destrument A, Tournier C: Physiological roles of MKK4 and MKK7: insights from animal models. Biochim Biophys acta. 2007, 1773: 1349-1357. 10.1016/j.bbamcr.2006.10.016.CrossRefPubMed
43.
Zurück zum Zitat Xu Z, Maroney AC, Dobrzanski P, Kukekov NV, Greene LA: The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol Cell Biol. 2001, 21: 4713-4724. 10.1128/MCB.21.14.4713-4724.2001.PubMedCentralCrossRefPubMed Xu Z, Maroney AC, Dobrzanski P, Kukekov NV, Greene LA: The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol Cell Biol. 2001, 21: 4713-4724. 10.1128/MCB.21.14.4713-4724.2001.PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Gallo KA, Johnson GL: Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol. 2002, 3: 663-672. 10.1038/nrm906.CrossRefPubMed Gallo KA, Johnson GL: Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol. 2002, 3: 663-672. 10.1038/nrm906.CrossRefPubMed
45.
Zurück zum Zitat Leung IW, Lassam N: The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation. J Biol Chem. 2001, 276: 1961-1967. 10.1074/jbc.M004092200.CrossRefPubMed Leung IW, Lassam N: The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation. J Biol Chem. 2001, 276: 1961-1967. 10.1074/jbc.M004092200.CrossRefPubMed
46.
Zurück zum Zitat Roux PP, Dorval G, Boudreau M, Angers-Loustau A, Morris SJ, Makkerh J, Barker PA: K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK. J Biol Chem. 2002, 277: 49473-49480. 10.1074/jbc.M203428200.CrossRefPubMed Roux PP, Dorval G, Boudreau M, Angers-Loustau A, Morris SJ, Makkerh J, Barker PA: K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK. J Biol Chem. 2002, 277: 49473-49480. 10.1074/jbc.M203428200.CrossRefPubMed
47.
Zurück zum Zitat Pan J, Zhang Q-G, Zhang G-Y: The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region. Neuroscience. 2005, 131: 147-159. 10.1016/j.neuroscience.2004.09.031.CrossRefPubMed Pan J, Zhang Q-G, Zhang G-Y: The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region. Neuroscience. 2005, 131: 147-159. 10.1016/j.neuroscience.2004.09.031.CrossRefPubMed
48.
Zurück zum Zitat Mishra R, Barthwal MK, Sondarva G, Rana B, Wong L, Chatterjee M, Woodgett JR, Rana A: Glycogen synthase kinase-3β induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3. J Biol Chem. 2007, 282: 30393-30405. 10.1074/jbc.M705895200.CrossRefPubMed Mishra R, Barthwal MK, Sondarva G, Rana B, Wong L, Chatterjee M, Woodgett JR, Rana A: Glycogen synthase kinase-3β induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3. J Biol Chem. 2007, 282: 30393-30405. 10.1074/jbc.M705895200.CrossRefPubMed
49.
Zurück zum Zitat Leung IW, Lassam N: Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3. J Biol Chem. 1998, 273: 32408-32415. 10.1074/jbc.273.49.32408.CrossRefPubMed Leung IW, Lassam N: Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3. J Biol Chem. 1998, 273: 32408-32415. 10.1074/jbc.273.49.32408.CrossRefPubMed
50.
Zurück zum Zitat Jope RS, Yuskaitis CJ, Beurel E: Glycogen synthase kinase-3 (GSK3) : inflammation, diseases, and therapeutics. Neurochem Res. 2007, 32: 577-595. 10.1007/s11064-006-9128-5.PubMedCentralCrossRefPubMed Jope RS, Yuskaitis CJ, Beurel E: Glycogen synthase kinase-3 (GSK3) : inflammation, diseases, and therapeutics. Neurochem Res. 2007, 32: 577-595. 10.1007/s11064-006-9128-5.PubMedCentralCrossRefPubMed
51.
Zurück zum Zitat Guha M, Mackman N: The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem. 2002, 277: 32124-32132. 10.1074/jbc.M203298200.CrossRefPubMed Guha M, Mackman N: The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem. 2002, 277: 32124-32132. 10.1074/jbc.M203298200.CrossRefPubMed
52.
Zurück zum Zitat Hoeflich KP, Luo J, Rubie EA, Tsao M-S, Jin O, Woodgett JR: Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature. 2000, 406: 86-90. 10.1038/35017574.CrossRefPubMed Hoeflich KP, Luo J, Rubie EA, Tsao M-S, Jin O, Woodgett JR: Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature. 2000, 406: 86-90. 10.1038/35017574.CrossRefPubMed
54.
Zurück zum Zitat Haefner B: A model for NF-kappa B regulation by GSK-3 beta. Drug Discov Today. 2003, 8: 1062-1063. 10.1016/S1359-6446(03)02898-8.CrossRefPubMed Haefner B: A model for NF-kappa B regulation by GSK-3 beta. Drug Discov Today. 2003, 8: 1062-1063. 10.1016/S1359-6446(03)02898-8.CrossRefPubMed
55.
Zurück zum Zitat Steinbrecher KA, Wilson W, Cogswell PC, Baldwin AS: Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription. Mol Cell Biol. 2005, 25: 8444-8455. 10.1128/MCB.25.19.8444-8455.2005.PubMedCentralCrossRefPubMed Steinbrecher KA, Wilson W, Cogswell PC, Baldwin AS: Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription. Mol Cell Biol. 2005, 25: 8444-8455. 10.1128/MCB.25.19.8444-8455.2005.PubMedCentralCrossRefPubMed
56.
Zurück zum Zitat Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G: Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol. 2002, 64: 963-970. 10.1016/S0006-2952(02)01161-9.CrossRefPubMed Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G: Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol. 2002, 64: 963-970. 10.1016/S0006-2952(02)01161-9.CrossRefPubMed
57.
Zurück zum Zitat Hayden MS, Ghosh S: Signaling to NF-κB. Genes Dev. 2004, 18: 2195-2224. 10.1101/gad.1228704.CrossRefPubMed Hayden MS, Ghosh S: Signaling to NF-κB. Genes Dev. 2004, 18: 2195-2224. 10.1101/gad.1228704.CrossRefPubMed
58.
Zurück zum Zitat Schmitz ML, Mattioli I, Buss H, Kracht M: NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem. 2004, 5: 1348-1358. 10.1002/cbic.200400144.CrossRefPubMed Schmitz ML, Mattioli I, Buss H, Kracht M: NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem. 2004, 5: 1348-1358. 10.1002/cbic.200400144.CrossRefPubMed
59.
Zurück zum Zitat Gong R, Rifai A, Ge Y, Chen S, Dworkin LD: Hepatocyte growth factor suppresses proinflammatory NFκB activation through GSK3β inactivation in renal tubular epithelial cells. J Biol Chem. 2008, 283: 7401-7410. 10.1074/jbc.M710396200.PubMedCentralCrossRefPubMed Gong R, Rifai A, Ge Y, Chen S, Dworkin LD: Hepatocyte growth factor suppresses proinflammatory NFκB activation through GSK3β inactivation in renal tubular epithelial cells. J Biol Chem. 2008, 283: 7401-7410. 10.1074/jbc.M710396200.PubMedCentralCrossRefPubMed
60.
Zurück zum Zitat Chen L-F, Greene WC: Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol. 2004, 5: 392-401. 10.1038/nrm1368.CrossRefPubMed Chen L-F, Greene WC: Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol. 2004, 5: 392-401. 10.1038/nrm1368.CrossRefPubMed
61.
Zurück zum Zitat Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M: Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J Biol Chem. 2003, 278: 2758-2766. 10.1074/jbc.M209572200.CrossRefPubMed Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M: Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J Biol Chem. 2003, 278: 2758-2766. 10.1074/jbc.M209572200.CrossRefPubMed
63.
Zurück zum Zitat Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK: c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia. 2005, 50: 235-246. 10.1002/glia.20173.CrossRefPubMed Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK: c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia. 2005, 50: 235-246. 10.1002/glia.20173.CrossRefPubMed
64.
Zurück zum Zitat Liu S, Yu S, Hasegawa Y, LaPushin R, Xu H-J, Woodgett JR, Mills GB, Fang X: Glycogen synthase kinase 3β is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase. J Biol Chem. 2004, 279: 51075-51081. 10.1074/jbc.M408607200.CrossRefPubMed Liu S, Yu S, Hasegawa Y, LaPushin R, Xu H-J, Woodgett JR, Mills GB, Fang X: Glycogen synthase kinase 3β is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase. J Biol Chem. 2004, 279: 51075-51081. 10.1074/jbc.M408607200.CrossRefPubMed
65.
Zurück zum Zitat Kim JW, Lee JE, Kim MJ, Cho E-G, Cho S-G: Glycogen synthase kinase 3β is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J Biol Chem. 2003, 278: 13995-14001. 10.1074/jbc.M300253200.CrossRefPubMed Kim JW, Lee JE, Kim MJ, Cho E-G, Cho S-G: Glycogen synthase kinase 3β is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J Biol Chem. 2003, 278: 13995-14001. 10.1074/jbc.M300253200.CrossRefPubMed
66.
Zurück zum Zitat Jope RS, Yuskaitis CJ, Beurel E: Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res. 2007, 32: 577-595. 10.1007/s11064-006-9128-5.PubMedCentralCrossRefPubMed Jope RS, Yuskaitis CJ, Beurel E: Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res. 2007, 32: 577-595. 10.1007/s11064-006-9128-5.PubMedCentralCrossRefPubMed
Metadaten
Titel
Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades
verfasst von
Mei-Jen Wang
Hsin-Yi Huang
Wu-Fu Chen
Hui-Fen Chang
Jon-Son Kuo
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
Journal of Neuroinflammation / Ausgabe 1/2010
Elektronische ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-7-99

Weitere Artikel der Ausgabe 1/2010

Journal of Neuroinflammation 1/2010 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie